tweenvest

Infant Bacterial Therapeutics AB (publ) (OM: IBT B)

Health Care · Pharmaceuticals · SE

Skr66.00

-9.96% today · +36.4% 1Y

Public summary
A free snapshot of Infant Bacterial Therapeutics AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Infant Bacterial Therapeutics AB (publ) (OM: IBT B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $88.30M.

Over the last twelve months the share price has gained 36.4%, trading between 43.25 and 84.90.

Tweenvest scores Infant Bacterial Therapeutics AB (publ) across four factors: quality 38/100, value 89/100. Its strongest factor is value.

IBT B price history

Nov 21, 2025 · 53.40Weekly closes 43.45 – 81.50Nov 13, 2026 · 66.00

Key figures

Market cap
$88.30M
Revenue (TTM)
—
P/E
-8.98
EPS
-20.53
Dividend yield
—
Beta (5Y)
0.28
52-week high
Skr84.90
52-week low
Skr43.25
Avg volume (3M)
—
Shares outstanding
13.47M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Nang Kuang Pharmaceutical Co., Ltd.TWSE: 1752$89.82MNT$29.35-2.17%
Vistin Pharma ASAOB: VISTN$89.76MNkr19.35+0.78%
Shree Ganesh Remedies LimitedBSE: 540737$89.31MRs654.00+2.26%
Kyongbo Pharmaceutical Co., LtdKOSE: A214390$88.53M₩4,950.000.00%
Unité de Fabrication des Médicaments S.ABVMT: UMED$88.23MDT8.27-0.36%
Polaryx Therapeutics, Inc.NasdaqCM: PLYX$88.23M$1.77-5.85%
Grown Rogue International Inc.CNSX: GRIN$87.50MCA$0.500.00%
BetterLife Pharma Inc.OTCPK: BETR.F$87.20M$0.14-6.62%

Browse every Pharmaceuticals company →